Vimarsana.com

Latest Breaking News On - Maker of coronavirus trial drug remdesivir - Page 1 : vimarsana.com

Gilead stock downgraded at Truist (NASDAQ:GILD)

Gilead stock downgraded at Truist (NASDAQ:GILD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Foster-city
California
United-states
Robyn-karnauskas
Justin-sullivan-getty
Gilead-sciences
Maker-of-coronavirus-trial-drug-remdesivir
Reports-positive-data-coming-from-trials
Getty-images
Truist-securities
Arcus-bioscience

Gilead stock drops as Trodelvy fails Phase 3 lung cancer trial (NASDAQ:GILD)

Gilead stock drops as Trodelvy fails Phase 3 lung cancer trial (NASDAQ:GILD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Merdad-parsey
Justin-sullivan-getty
Gilead-sciences
Maker-of-coronavirus-trial-drug-remdesivir
Reports-positive-data-coming-from-trials
Getty-images

Gilead's Dividend Growth Potential Looks Phenomenal (NASDAQ:GILD)

Gilead's Dividend Growth Potential Looks Phenomenal (NASDAQ:GILD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Justin-sullivan
Gilead-dividend-health
Gilead-sciences
Maker-of-coronavirus-trial-drug-remdesivir
Reports-positive-data-coming-from-trials
Cell-therapy
Seeking-alpha

Without A Clear Growth Path, Gilead Sciences Is A Hold (NASDAQ:GILD)

Without A Clear Growth Path, Gilead Sciences Is A Hold (NASDAQ:GILD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United-states
Merdad-parsey
Justin-sullivan
Johanna-mercier
Gilead-sciences
Forty-seven-inc
Maker-of-coronavirus-trial-drug-remdesivir
Reports-positive-data-coming-from
Kite-pharma
Forty-seven
Seeking-alpha
Fast-graphs

Gilead stock in 2024: What to expect? (NASDAQ:GILD)

Gilead stock in 2024: What to expect? (NASDAQ:GILD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Foster-city
California
United-states
American
Veklury-remdesivir
Salim-syed
Justin-sullivan
Leo-nelissen
Gilead-sciences
Wells-fargo
American-society-of-hematology
Maker-of-coronavirus-trial-drug-remdesivir

Compugen stock rockets 160% on Gilead development deal (NASDAQ:CGEN)

Compugen stock rockets 160% on Gilead development deal (NASDAQ:CGEN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Israel
Israeli
Justin-sullivan-getty
Gilead-sciences
Compugen
Maker-of-coronavirus-trial-drug-remdesivir
Reports-positive-data-coming-from-trials
Getty-images
Investigational-new-drug

Gilead Sciences Stock Is Building A Diversified Portfolio (NASDAQ:GILD)

Gilead Sciences Stock Is Building A Diversified Portfolio (NASDAQ:GILD)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Justin-sullivan
Gilead-sciences
Gilead-sciences-investor-presentation
Gilead-sciences-milestones
Gilead-sciences-quarterly
Gilead-sciences-accelerating-cancer-business
Nasdaq
Gilead-sciences-inc
Gilead-sciences-shareholder
Maker-of-coronavirus-trial-drug-remdesivir
Reports-positive-data-coming-from-trials
Cell-therapy

Dividend Increases: January 29-February 4, 2022

In this article series, we provide a weekly summary of dividend changes. Check out why we highlight Gilead Sciences (GILD) stock in this list.

Australia
Rye-brook
New-york
United-states
United-kingdom
Minnesota
California
New-mexico
Secaucus
New-jersey
Dublin
Ireland

Dead Money: Gilead's Stock Faces Declines (NASDAQ:GILD)

With no prospects for revenue or earnings growth, Gilead stock appears to be going lower to start 2022. Read more about GILD stock here.

Justin-sullivan-getty
Gilead-sciences
Maker-of-coronavirus-trial-drug-remdesivir
Reports-positive-data-coming-from
Reading-the-markets

vimarsana © 2020. All Rights Reserved.